Post by Andreas Santoro

€𝟯.𝟮𝗠. It actually happened. Led by YZR Capital and DN Capital, with Angel Invest, ZOHO and Better Ventures. The money isn't the point. The point is that some of the most experienced investors in healthcare and applied AI are taking this bet with us on a thesis that, a year ago, plenty of people thought wasn't buildable. Chronic disease is the most expensive and deadliest category in every healthcare system on earth. The data to detect it early already exists. Physicians see less than 3% of it before making a decision. A third of cases are missed at the point where they could still be treated. At dehaze, we're building the foundational model that closes that gap. In Munich, from first principles, without shortcuts via generic LLMs. What I take from the last year: when people say "from first principles," they usually don't mean it. We did. It was harder than I expected. To the team, to Marius, to our investors: thank you for believing early. We're hiring! Sven Schneider Sandow, christian Ratsch, @Bülent Cakir, Roland Levillain Grenke, Andreas W. Lanyi, Joseph Hewitt Carnarius, Florian Krueger Hoppen, marius opsomer Rosenberg, Florian Krueger Schweitzer, Christoph Gürtler Behn, Robert K. Chu Levenhagen, Nina Rodgers Kani, Markus Valo Feuerecker, Till Kleinhans Qui, Ian Chiaying Wang Marsh, Gülsah S Wilke, Celine C. Xiao, Karl Johan Grøttum Seilern, Major L. Schilling, Nicole Cayon Sievers